Research and Clinical Center for Infertility, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.
Andrologia. 2012 May;44 Suppl 1:194-8. doi: 10.1111/j.1439-0272.2011.01163.x. Epub 2011 Jun 8.
About 10% of infertile men have azoospermia. After the introduction of microinjection [intracytoplasmic sperm injection (ICSI)], many of these men obtain the chance to be a father. But still in many cases of nonobstructive azoospermia, we are not able to find spermatozoa for ICSI. Medications may be able to increase the chance of finding spermatozoa in testis samples. So in this study, we evaluated the effect of tamoxifen citrate on the results of sperm recovery from testis tissue in infertile men with nonobstructive azoospermia. Thirty-two azoospermic infertile men with proved nonobstructive azoospermia were selected. Tamoxifen was administered for 3 months. Semen samples and in the cases of azoospermia second testis biopsy were taken, and the results were compared with the first samples. According to first testis samples, 13 patients had hypospermatogenesis, 9 had maturation arrest and 10 patients sertoli cell syndrome. After tamoxifen treatment, six patients showed spermatozoa in their ejaculates. From other patients all in hypospermatogenesis group, 75% in maturation arrest group and 20% in sertoli cell group showed spermatozoa in their second testis samples. Our study showed that treatment of patients with nonobstructive azoospermia with anti-oestrogenic drugs like tamoxifen can improve the results of sperm recovery in testis samples and also increase the chance of pregnancy by microinjection.
大约 10%的不育男性患有无精子症。在引入显微注射(卵胞浆内单精子注射 [ICSI])后,许多此类男性获得了成为父亲的机会。但在许多非阻塞性无精子症的情况下,我们仍然无法在睾丸样本中找到精子用于 ICSI。药物可能能够增加在睾丸组织中找到精子的机会。因此,在这项研究中,我们评估了枸橼酸他莫昔芬对非阻塞性无精子症不育男性睾丸组织精子回收结果的影响。选择了 32 名证实患有非阻塞性无精子症的无精子症不育男性。给予他莫昔芬治疗 3 个月。采集精液样本和无精子症的第二次睾丸活检样本,并将结果与第一次样本进行比较。根据第一次睾丸样本,13 名患者表现为少精子症,9 名患者表现为成熟阻滞,10 名患者表现为 sertoli 细胞综合征。在他莫昔芬治疗后,6 名患者的精液中出现了精子。在其他患者中,所有少精子症组、75%的成熟阻滞组和 20%的 sertoli 细胞组的第二次睾丸样本中均出现了精子。我们的研究表明,用抗雌激素药物如他莫昔芬治疗非阻塞性无精子症患者可以改善睾丸样本中精子回收的结果,并通过显微注射增加怀孕的机会。